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HypervirulentClostridium difﬁcile is a leading cause of healthcare-associated diarrhoea. In recent years, certain C. difﬁcile
types have become highly represented among clinical isolates and are associated with outbreaks of increased
disease severity, higher relapse rates and an expanded repertoire of antibiotic resistance. Endospores,
produced during sporulation, play a pivotal role in infection and disease transmission and it has been
suggested in the literature that these so-called ‘hypervirulent’ C. difﬁcile types are more proliﬁc in terms of
sporulation in vitro. However, work in our laboratory has provided evidence to the contrary suggesting that
although there is signiﬁcant strain-to-strain variation in C. difﬁcile sporulation characteristics this variation
does not appear to be type-associated. On analysis of the literature, it is apparent that the methods used to
quantify sporulation in previous studies have varied greatly and sample sizes have remained small. The
conﬂicting data in the literature may, therefore, not necessarily be generally representative of C. difﬁcile
sporulation. Instead, these inconsistencies may reﬂect differences in the experimental design of each study. In
this review, the need for further investigations of C. difﬁcile sporulation rates is highlighted. Speciﬁcally, the
advantages and disadvantages of the different experimental approaches previously used are discussed and a
standard set of principles for measuring C. difﬁcile sporulation in the future is proposed.: +44 115 82 32120.
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Clostridium difﬁcile is a leading cause of hospital-acquired diar-
rhoea and a major burden to healthcare services worldwide. In recent
years, C. difﬁcile infection (CDI) has led to patient isolation, wardclosures and, in some cases, hospital closure. In the United States of
America alone, CDI is estimated to affect over 500,000 people each
year and is estimated to cost the healthcare system over $3 billion
per year (Cloud and Kelly, 2007; Rupnik et al., 2009). Endospores,
produced during sporulation, are pivotal to disease transmission.
These spores are able to resist a variety of physical and chemical
agents (Setlow, 2007), allowing for C. difﬁcile persistence on surfaces
in the healthcare setting. The subsequent inadvertent ingestion of
contaminatedmaterial leads to infection or re-infection of co-habiting
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anaerobic environment of the gut, the ingested spores presumably
germinate to form toxin-producing vegetative cells and, in susceptible
individuals, cause diarrhoeal disease.
The emergence of C. difﬁcile strains belonging to restriction endo-
nuclease type BI, North American pulsed-ﬁeld type 1 (NAP1) and PCR-
ribotype 027 (BI/NAP1/027) has contributed to the problem of
C. difﬁcile incidence (Kuijper et al., 2007; Pépin et al., 2004). These
so-called ‘hypervirulent’ types were in the past isolated infrequently
from patients suffering from CDI but have recently become highly
represented among such clinical isolates. In addition, emerging strains
belonging to PCR-ribotype 017 and 078, that are also associated with
severe disease, have been isolated in parts of Asia and Europe (Drudy
et al., 2007; Kim et al., 2008). Unsurprisingly, there is a widespread
interest in understanding the underlying factors that have led to the
emergence of hypervirulent C. difﬁcile strains, such as those of the BI/
NAP1/027 type.
As the spore form is considered to be the vehicle for the trans-
mission of CDI, knowledge of how sporulation characteristics vary
among strains is important. A number of recent studies have con-
cluded that ‘epidemic’ and hypervirulent C. difﬁcile types are more
proliﬁc in terms of sporulation in vitro than non-epidemic types
(Akerlund et al., 2008; Fawley et al., 2007;Merrigan et al., 2010; Vohra
and Poxton, 2011; Wilcox and Fawley, 2000). To the contrary, data
from our laboratory suggest that although there is substantial var-
iation in C. difﬁcile sporulation characteristics this variation does not
appear type-associated (Burns et al., 2010a). Importantly, four of the
above studies included the same C. difﬁcile strain in their analysis but
the conclusions as to its sporulation proﬁciency were not consistent
(Akerlund et al., 2008; Burns et al., 2010a;Merrigan et al., 2010; Vohra
and Poxton, 2011). Interestingly, the methods used to quantify spor-
ulation have varied signiﬁcantly from study to study and, currently,
there is no accepted ‘gold standard’ procedure for quantifying
C. difﬁcile sporulation. For this reason, the differences in the ﬁndings
of these studies may reﬂect the experimental approaches employed
and, while the overall ﬁndings of each study are important, some of
these data may have been misinterpreted based on small sample sizes
and methods that cannot quantify sporulation independently of other
important properties.
The intention of this article is to compare the methods previously
used to assess C. difﬁcile sporulation characteristics and discuss how
varying the experimental designmay lead to a different interpretation
of the data. Furthermore, we propose a standard set of procedures to
be considered when quantifying C. difﬁcile sporulation, which may be
generally deployed in the future to better understand the character-
istics of emerging, clinically important C. difﬁcile types.
2. Quantifying C. difﬁcile sporulation
When attempting to gain a quantitative measurement of C. difﬁcile
sporulation, it is important to ensure that the resultant data are
representative of sporulation alone. Accordingly, sporulation must be
measured independently of factors such as vegetative cell growth,
the death of non-sporulating cells, spore resistance properties, spore
germination and the subsequent vegetative cell outgrowth. Recently, a
number of different approaches have been used to quantify C. difﬁcile
sporulation. The advantages and disadvantages of each approach are
discussed below.
2.1. Measuring sporulation based on colony-forming units
Perhaps the most widely used method for enumerating C. difﬁcile
spores involves measuring colony-forming units (CFU) on agar plates
after a stress treatment such as heat or ethanol shock (Buckley et al.,
2011; Goulding et al., 2009; Kamiya et al., 1992; Kuehne et al., 2010;
Lyras et al., 2009; Poxton et al., 2001; Sambol et al., 2001). C. difﬁcilespores are able to survive incubation at 60–80 °C for 10–30 min or
incubation with up to 100% ethanol for an extended period of time
(Setlow, 2006; Setlow, 2007). The rationale of this approach is that
only spores will survive the treatment and the colonies recovered on
plates are, therefore, representative of spores within the population.
By analysing the change in stress-resistant CFU over a deﬁned period
of time it is then possible to measure the development of spores
within a liquid culture and consequently estimate the rate at which
C. difﬁcile forms spores (Burns, et al., 2010a). However, the CFU
obtained after exposure to heat or ethanol shock represent vegetative
cells that have (i) completed sporulation; (ii) resisted the heat/
chemical treatment; (iii) completed germination; and (iv) returned to
vegetative cell growth. When studying different strains of C. difﬁcile,
or even different mutants derived from the same C. difﬁcile parental
strain, it is important to consider that there will likely be variation in
characteristics such as cell growth rate, spore resistance properties
and germination proﬁciency. Indeed, our recent analysis of C. difﬁcile
clinical isolates indicated that there was signiﬁcant variation in the
proportion of spores that form colonies on nutrient-rich medium
following heat treatment (Burns, et al., 2010a). Consequently, the
number of observed stress-resistant CFU is not directly comparable to
the number of spores within the same culture and measurements of
CFU should always be combined with another procedure, such as
analysis by phase-contrast microscopy (see Section 2.2), in order to
accurately observe spore numbers.
As spores must complete germination in order to form colonies, it
is also important that CFU are enumerated on a medium that is
appropriately supplemented to support efﬁcient germination. This
is often achieved using the bile salt taurocholate which, when added
to rich medium, has been shown to result in approximately 105-fold
higher recovery of spores when compared to medium lacking tau-
rocholate (Sorg and Sonenshein, 2008; Wilson et al., 1982). A recent
study analysed the spore titres of a number of C. difﬁcile strains by
enumerating ethanol-resistant CFU on blood agar plates (Vohra and
Poxton, 2011). However, the medium was not supplemented with
taurocholate and the highest number of CFU recovered from the ﬁve
tested strains was an average of 443 CFU/ml. The proportion of spores
recovered for each strain would likely have been signiﬁcantly higher
using medium supplemented with taurocholate. Therefore, the
differences observed among strains in this study were small, making
statistical validation of the data problematic.
2.2. Counting C. difﬁcile spores using phase-contrast microscopy
A simple means to measure sporulation independently of other
characteristics is to enumerate spores using phase-contrastmicroscopy.
Such an approach allows for a measurement of the exact number of
spores in a population aswell as, for comparativemeans, the number of
vegetative cells present in the same population. Phase-bright spores are
generally easily distinguished from vegetative cells when observed by
microscopy, but a number of studies have reported using speciﬁc
staining procedures to further ease this distinction (Fawley et al., 2007;
Underwood et al., 2009). An example of such amethod is the Schaeffer–
Fulton endospore stain (Mormak and Casida, 1985). This involves a
primary malachite green stain which traverses the spore coat on heat
treatment but is retained within the coat after cooling. A safranin
counter-stain is then taken up by vegetative cells but not by spores,
resulting in spores appearing as green and vegetative cells appearing as
pinkwhen observed bymicroscopy. The ideal way to then count spores
or cells in this manner is to use a specialised counting chamber such as
a haemocytometer, and examples of using this approach to count
C. difﬁcile spores have been described (Akerlund et al., 2006; Burns et al.,
2010a; Burns et al., 2010b).
Despite the beneﬁt of using counting chambers to measure the
number of spores within a suspension, some recent studies have ex-
pressed sporulation differently. In a study byMerrigan and co-workers,
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terms of sporulation, the numbers of spores per ﬁeld at 100× mag-
niﬁcation were enumerated (Merrigan et al., 2010). Such a procedure
allows for an accurate comparison of spore numbers among different
cultures, although it must be noted that four of the eight strains tested
returned a mean count of b5 spores per ﬁeld when 10 ﬁelds were
observed. Consequently, it could be argued that these countsmay not be
satisfy the necessary criteria formeasurements of statistical signiﬁcance
and their ﬁndings may require further veriﬁcation.
2.3. Expressing sporulation as the percentage of spores within a
population
A study by Akerlund and co-workers has also concluded that BI/
NAP1/027 strains exhibit higher sporulation rates than non-epidemic
strains (Akerlund et al., 2008). In this study, although both spores and
vegetative cells were enumerated using a counting chamber, the
sporulation rate was expressed as the ratio of spores to vegetative
cells within the population after 48 h incubation, an approach other
studies have used in a similar manner (Fawley et al., 2007;
Underwood et al., 2009; Wilcox and Fawley, 2000). These measure-
ments are important, as the raw data can provide information on both
the spore titre and the fate of non-sporulating vegetative cells.
However, when only a spore-to-cell ratio is reported, it is not possible
to distinguish between these two factors, or indeed the generic
growth characteristics of the isolates studied. As an example, if two C.
difﬁcile strains were found to form spores in equal numbers over a
deﬁned time period and the same proportion of vegetative cells
initiated sporulation in each strain, the subsequent sporulation rates
of both strains should be expressed as equal. However, following the
initiation of sporulation, if more non-sporulating vegetative cells were
to survive in one strain than in another, a higher vegetative cell count
would then lower the percentage of spores in the population when
the suspensions are analysed by microscopy. As a result, two strains
forming identical numbers of spores may be described to have dif-
ferent sporulation characteristics. For these reasons, by only reporting
the percentage of spores present within a population, it may not be
possible to make precise assumptions on sporulation rates. A more
comprehensive study might combine such an analysis with the actual
number of spores counted in the suspension. Accordingly, an accurate
argument could then be made regarding both sporulation proﬁciency
and the fate of vegetative cells that do not enter the sporulation
process.
2.4. Concluding remarks
Clearly, the precise methods recently used to quantify C. difﬁcile
sporulation have varied greatly from study to study. Based on the
limitations of each approach described above, there is a risk that,
while interesting observations have been made, these observations
are not readily comparable. Furthermore, some of these data may not
be truly representative of differences in sporulation rates among the
C. difﬁcile strains tested. We feel that phase-contrast microscopy
analysis is essential when enumerating C. difﬁcile spore titres and this
should be based on either the use of a counting chamber or by com-
paring the number of spores observed per ﬁeld of view. Furthermore,
regardless of what further analysis is undertaken, the spore count
should always be supplied to avoid misinterpretations of data by
either authors or readers.
3. Further experimental procedures
When analysing C. difﬁcile sporulation, the procedures used to
enumerate spores are only one aspect to consider. Differences in the
basic experimental setup among studies may affect the results even
when the sameC.difﬁcile strains are evaluated. Todate, four independentstudies have analysed theC.difﬁcile reference strainVPI 10463.However,
the conclusions of these studies were not consistent regarding the
sporulation proﬁciency of this strain (Akerlund et al., 2008; Burns et al.,
2010a; Merrigan et al., 2010; Vohra and Poxton, 2011). Important
variations in the experimental setups of these studies are discussed
below in an effort to understand how these conﬂicting reportsmay have
arisen.
3.1. Growth conditions
In spore-forming organisms such as Bacillus subtilis, it is well
established that sporulation efﬁciency varies greatly depending on the
choice of growth medium (Errington, 1993). Therefore, it stands to
reason that altering the growth medium may also affect C. difﬁcile
sporulation.
Perhaps the most widely used medium for inducing C. difﬁcile
sporulation is brain-heart infusion (BHI) supplemented with L-cysteine
and yeast extract (BHIS), and a number of studies have used either this
medium, or a non-supplemented BHI, to measure C. difﬁcile sporulation
and to prepare spores for subsequent analyses of spore germination
(Burns et al., 2010a,b;Merrigan et al., 2010; Sorg and Sonenshein, 2008,
2009, 2010; Underwood et al., 2009). Use of a different medium was
described in a study by Akerlund et al., where C. difﬁcile strains were
cultivated in a peptone-yeast medium with added cysteine (Akerlund
et al., 2006).However, in laterwork by the samegroup, cysteinewasnot
added to the peptone-yeast sporulation medium (Akerlund, et al.,
2008). The decision not to include cysteine in this sporulation medium
could be explainedbasedon reported evidence that cysteinemay inhibit
C. difﬁcile toxin production when added to late-exponential-phase
cultures (Karlsson et al., 2008), as toxin productionwas also analysed in
this study (Akerlund et al., 2008). Finally, two other studies have used a
faecal emulsion to prepare C. difﬁcile spores, an approach that is
particularly interesting as these conditions will likely mimic the natural
in vivo environment of C. difﬁcile (Fawley et al., 2007; Wilcox and
Fawley, 2000).
Our knowledge of C. difﬁcile sporulation mechanisms remains
limited, with few studies reported to date (Heap et al., 2007;
Underwood, et al., 2009). For this reason, it is not clear exactly what
the desirable components of a sporulation medium are. Likewise, it is
not clearwhat components of currently used sporulationmediamay be
having a limiting effect on sporulation. Studies describing in detail the
effects of different media on C. difﬁcile sporulation would, therefore, be
welcomed in the future.
3.2. Examining sporulation over time
To gain a detailed insight into C. difﬁcile sporulation rates, it is
important to measure spore formation over multiple time-points.
Such an analysis can allow for a distinction of (i) when sporulation is
initiated; and (ii) the total number of spores that a particular strain
produces under the growth conditions employed. Ideally, to measure
the total number of spores produced, sporulation should be measured
every 24 h until the number of spores reaches a steady state. The exact
period of time required for completion of the sporulation process in
C. difﬁcile is still not clear, although data from our laboratory suggest
that this process is generally complete after 120 h (Burns et al.,
2010a). However, we noted that not all of the strains tested in our
study formed a maximal number of spores within 120 h. Consequent-
ly, the substantial variation in sporulation characteristics observed
among strainsmay, in some cases, require a longer incubation in order
to observe the total number of spores produced.
Other studies of C. difﬁcile sporulation rates have been limited to a
time-course of between 24 h and 72 h (Akerlund et al., 2008; Fawley
et al., 2007; Merrigan et al., 2010; Vohra and Poxton, 2011; Wilcox
and Fawley, 2000). We observed that a low spore titre at 24 h in
comparison to other isolates did not necessarily correlate to a low
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appeared to form few spores after 24 h, a high number of spores was
observed after 120 h (Burns, et al., 2010a). This observation is
interesting as other studies have suggested that VPI 10463 is a strain
with a low sporulation frequency (Akerlund, et al., 2008; Merrigan,
et al., 2010; Vohra and Poxton, 2011). However, when taking into
account our data, the previous studies may not have observed
sporulation for a sufﬁcient time to obtain a total spore count. As a
result, it may be inaccurate to describe VPI 10463 as a low-sporulating
C. difﬁcile strain. On the other hand, when compared to other
individual strains, a high number of spores observed in our study
after 24 h did not always result in high numbers of spores after 120 h
when compared to other strains (Burns, et al., 2010a). This suggests
that in a case where a strain initiates sporulation particularly early,
such a strain may not necessarily form a higher number of spores than
a strain which initiates sporulation at a later stage.
3.3. Controls
When studying C. difﬁcile sporulation, three important controls are
required. First, it should always be considered that generic growth
differencesmay exist among different C. difﬁcile strains. Consequently,
diverse spore titres may not necessarily be a direct result of spor-
ulation per se but instead a consequence of growth. By analysing the
change in optical density at 600 nm (OD600) growth differences,
where appropriate, can be excluded when interpreting subsequent
experiments. The majority of recent studies have included such
measurements (Akerlund et al., 2008; Burns et al., 2010a, 2010b;
Merrigan et al., 2010; Underwood et al., 2009; Vohra and Poxton,
2011), although it must be noted that some similar studies have
elected not to include this analysis (Fawley, et al., 2007; Wilcox and
Fawley, 2000).
Second, if sporulation is being observed over a deﬁned time-
period, it is important to conﬁrm that as few spores as possible are
present in the sporulation medium at 0 h. Excessive carryover of
spores from previous passages would suggest that sporulation has
been initiated within the culture prior to the start of the experiment.
This may in turn affect the rate of subsequent sporulation when
compared to a culture where no spores are present at 0 h and could,
therefore, lead to a bias among spore counts. Only one other study
outside of our laboratory has included a measurement of sporulation
at 0 h (Vohra and Poxton, 2011) and we suggest that this is an
important issue to be considered when analysing C. difﬁcile sporula-
tion in the future. To ensure minimal spores are present at 0 h, strains
can be repeatedly sub-cultured on solid media prior to starting the
experiment. A starter culture can then be prepared with a 1%
inoculum of an overnight culture and incubated until an OD600 of
between 0.2 and 0.5 is reached. Finally, the sporulation medium is
inoculated with a 1% inoculum of this starter culture (Burns et al.,
2010a).
The third fundamental control required is a sporulation-negative
control. This is especially important when analysing CFU after stress
treatments such as heat and ethanol as, even though vegetative cells
would likely be killed by the treatment, simple errors in experimental
technique could lead to erroneous CFU due to (i) contamination of
solutions used in serial dilutions; (ii) contamination when plating; or
(iii) incomplete heat/ethanol treatment. The ideal C. difﬁcile sporula-
tion-negative control is a spo0Amutant, where themaster regulator of
sporulation has been inactivated (Heap et al., 2007), and this strain is
available upon request from our laboratory. Alternatively, a culture
conﬁrmed to be free of spores by microscopy, following repeated sub-
culture with appropriate media, can control for errors in experimental
technique when analysing CFU. However, this latter control can only
identify technical errors during stress treatments and not the
contamination of sporulation cultures at the beginning of the study.
In that respect, a spo0A control is the more appealing option. Only oneother study outside of our laboratory has used a negative control
when measuring C. difﬁcile sporulation (Underwood et al., 2009).
Based upon this evidence, the lack of appropriate controls in a number
of previous studies (Akerlund et al., 2008; Fawley et al., 2007;
Merrigan et al., 2010; Vohra and Poxton, 2011; Wheeldon et al., in
press; Wilcox and Fawley, 2000) may perhaps make it difﬁcult to
validate the results.
3.4. Sample sizes
When assessing the characteristics of a particular group of strains,
such as the C. difﬁcile BI/NAP1/027 type, it is important to study as
many representatives of that group as is possible in order to improve
conﬁdence in the data. Our recent analysis of C. difﬁcile sporulation
included seven BI/NAP1/027 strains, including isolates from both
North America and Europe to minimize the risk of sampling clonal
strains, and we observed signiﬁcant variation in sporulation proﬁ-
ciency within the BI/NAP1/027 group (Burns et al., 2010a). This
diversity within one group of seven C. difﬁcile strains suggests that, in
order to accurately determine variation in sporulation between
different groups, an appropriate sample size will be much larger
than seven strains. However, while the sample used in our study was
not particularly large, this does represent the largest sample size used
to-date in such a study. Other reports of C. difﬁcile sporulation rates
have been limited to as few as one representative strain of each type
(Fawley et al., 2007; Vohra and Poxton, 2011; Wilcox and Fawley,
2000). A small sample size of this nature is clearly appropriate for
initial investigations, such as the study by Wilcox and Fawley (2000),
but the continued use of small sample sizesmay be contributing to the
conﬂicting evidence that is currently present in the literature. For this
reason, it seems obvious that all future C. difﬁcile strain comparisons,
not only those studies of sporulation rates, should be based on a
much larger group of strains. Furthermore, the sporulation diversity
previously observedwithin the BI/NAP1/027 type suggests that it may
be incorrect to assume that all strains of this type have similar
characteristics.
4. Conclusions and future directions
The spore form of C. difﬁcile is crucial for disease transmission in
healthcare environments. Spores can contaminate the surroundings
of patients with CDI and persist for extensive periods of time. Strains
of C. difﬁcile that are found to have increased sporulation proﬁciencies
are, therefore, of particular concern. There have been reports that
‘hypervirulent’ types of C. difﬁcile can produce more toxin in the
laboratory (Warny et al., 2005) and recently a number of studies have
concluded that these emerging C. difﬁcile types are more proliﬁc in
terms of sporulation in vitro (Akerlund et al., 2008; Fawley et al., 2007;
Merrigan et al., 2010; Vohra and Poxton, 2011; Wilcox and Fawley,
2000). Given the importance of spores for disease transmission, it is
tempting to assume that this reported phenomenon is correct.
However, work in our laboratory has since provided credible evidence
to the contrary suggesting that the strain-to-strain variation in
C. difﬁcile sporulation characteristics is not type-associated (Burns
et al., 2010a). Therefore, it can be argued that the current literature
contains insufﬁcient evidence to conclude that epidemic C. difﬁcile
types form spores with greater efﬁciency compared to other types and
this may be due in part to the variety of techniques used to assess
sporulation characteristics in previous investigations.
This review has examined the methods used in recent studies to
analyse sporulation, discussing the advantages and disadvantages of
each approach. Using the experimental designs described in a number
of studies, accurate judgements may not have been made on the
sporulation proﬁciencies of the tested C. difﬁcile strains. Consequently,
the sporulation rates of emerging strains of C. difﬁcile may not in fact
differ to non-epidemic types. If this is the case, readers who are not
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by the literature that is currently available. As a result, and in an effort
to increase the clarity of future studies, we now propose a set of
standard principles to be considered when analysing C. difﬁcile
sporulation. In Fig. 1, we illustrate an experimental design that is
capable of distinguishing between factors such as (i) vegetative cell
growth; (ii) sporulation rate; (iii) total sporulation; (iv) the fate of
non-sporulating vegetative cells; (v) spore stress resistance; and
(vi) spore germination and outgrowth.
By measuring sporulation over a period of at least 120 h it is
possible to obtain an accurate account of the total number of spores
produced and by taking measurements at multiple time-points the
rate of sporulation can be expressed more precisely. We suggest that
exact spore titres should be enumerated using phase-contrast
microscopy and that this measurement should always be present
when describing spore numbers. Additional assessments of sporula-
tion may involve the analysis of stress-resistant CFU and the
proportion of spores to vegetative cells within a population at deﬁned
time-points. We consider that suitable controls are mandatory when
measuring sporulation. It is important that growth differences among
strains are excluded before data on spore titres can be interpreted
and, while particularly important when analysing CFU after stress
treatments, the principle of ensuring no spores are present at 0 h also
applies to studies where sporulation is enumerated in a different
manner. In addition, any future report of C. difﬁcile sporulation char-
acteristics must include a sporulation-negative control in order to
gain conﬁdence in the data. Finally, we suggest that the sample sizes
used in future studies are substantially increased to account for the
signiﬁcant variation in sporulation characteristics within C. difﬁcile
types.
The view of increased sporulation rates among hypervirulent
C. difﬁcile types is continually being spread at international meetings,
as well as in print. Predictably, given the clinical importance of BI/
NAP1/027 strains a substantial amount of time and funding is now
being utilised to investigate the molecular and epidemiological basis
of virulence in this type. Consequently, it is possible that current
research directions associated with the sporulation mechanisms of
C. difﬁcilemay be based on incorrect preliminary data. This review has
highlighted the need for further investigations of C. difﬁcile sporula-Fig. 1. A proposed experimental format for future investigations of C. difﬁcile
sporulation characteristics. This ﬂowchart details the principles that, when applied
together, can independently assess (i) vegetative cell growth rate; (ii) sporulation rate;
(iii) total sporulation at a deﬁned point; and (iv) the fate of vegetative cells that do not
form spores. In addition, the suitable controls described in the text ensure that resultant
data are not affected by technical errors.tion rates using a standard set of experimental procedures and larger
sample sizes. Accordingly, we aim to evoke discussion within the
C. difﬁcile ﬁeld of how sporulation should bemeasuredwith the aim of
agreeing on a standard assay that can ﬁrmly interpret how emerging,
hypervirulent C. difﬁcile types differ from those types not associated
with outbreaks of severe disease.
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